US · 21 CFR
21 CFR 601.44
Postmarketing safety reporting.
21 CFR Part 601 › Subpart E—Accelerated Approval of Biological Products for Serious or Life-Threatening Illnesses
조항 원문
Biological products approved under this program are subject to the postmarketing recordkeeping and safety reporting applicable to all approved biological products.
본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.
출처: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · 수집일 2026-11-16